Endo Pharmaceuticals News
Most Popular Endo Pharmaceuticals Story
Endo shares sink after FDA rejects Aveed NDA
Shares of Endo Pharmaceuticals (ENDP) slid this morning after investors got wind of the news that the FDA stiff-armed the company's application to market its new drug for low testosterone. Low Read more...
Latest Headlines
- August 18, 2011
- June 30, 2011
- January 28, 2011
- January 13, 2011
- December 30, 2010
- August 31, 2010
- August 10, 2010
- December 3, 2009
- November 30, 2009
- August 26, 2009
- July 10, 2009
- June 11, 2009
- January 30, 2009
- January 6, 2009
- April 8, 2008
- February 20, 2008
- October 1, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
